var title_f21_58_22432="Angle of bronchial puncture";
var content_f21_58_22432=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F70074&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F70074&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Angle of transbronchial puncture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 255px; height: 339px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The TBNA needle should make an angle &gt;45&ordm; with the airway wall.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Minai, OA, Dasgupta, A, Mehta, AC. Transbronchial needle aspiration of central and peripheral lesions. In: Bolliger, CT, Mathur, PN (Eds), Progress in Respiratory Research-Interventional Bronchoscopy. Karger, Basel, Switzerland, 1999.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22432=[""].join("\n");
var outline_f21_58_22432=null;
var title_f21_58_22433="Hepatic hematoma rupture MRI";
var content_f21_58_22433=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F68521&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F68521&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hepatic hematoma with rupture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 297px; height: 289px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Magnetic resonance image from a pregnant woman with hepatic hematoma with rupture. This cut shows collected blood under the hepatic capsule running from the dome of the liver down along the right side, pushing the remaining normal parenchyma towards the midline.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Barton, JR, Sibai, BM, Am J Obstet Gynecol 1996; 174:1820.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22433=[""].join("\n");
var outline_f21_58_22433=null;
var title_f21_58_22434="Patient information: Insomnia (The Basics)";
var content_f21_58_22434=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16177\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/53/4955\">",
"         Consensus Sleep Diary",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_table\" href=\"UTD.htm?13/62/14318\">",
"          Consensus Sleep Diary Instructions",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?38/4/38978\">",
"         Patient information: Daytime sleepiness (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?19/9/19602\">",
"         Patient information: Jet lag (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?20/29/20946\">",
"         Patient information: Restless legs syndrome (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/5/35921\">",
"         Patient information: What is a sleep study? (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?2/16/2306\">",
"         Patient information: Insomnia (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/24/28035\">",
"         Patient information: Insomnia treatments (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Insomnia (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/insomnia-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H17011166\">",
"      <span class=\"h1\">",
"       What is insomnia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Insomnia is a problem with sleep. People with insomnia have trouble falling or staying asleep, or they do not feel rested when they wake up. Insomnia is not about the number of hours of sleep a person gets. Everyone needs a different amount of sleep.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17011181\">",
"      <span class=\"h1\">",
"       What are the symptoms of insomnia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People with insomnia often:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Have trouble falling or staying asleep",
"       </li>",
"       <li>",
"        Feel tired or sleepy during the day",
"       </li>",
"       <li>",
"        Forget things or have trouble thinking clearly",
"       </li>",
"       <li>",
"        Get cranky, anxious, irritable, or depressed",
"       </li>",
"       <li>",
"        Have less energy or interest in doing things",
"       </li>",
"       <li>",
"        Make mistakes or get into accidents more often than normal",
"       </li>",
"       <li>",
"        Worry about their lack of sleep",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      These symptoms can be so bad that they affect a person&rsquo;s relationships or work life. Plus, they can happen even in people who seem to be sleeping enough hours.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17011190\">",
"      <span class=\"h1\">",
"       Are there tests I should have?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Probably not. Most people with insomnia need no tests. Your doctor or nurse will probably be able to tell what is wrong just by talking to you. He or she might also ask you to keep a daily log for 1 to 2 weeks, where you keep track of how you sleep each night (",
"      <a class=\"graphic graphic_figure graphicRef87134 \" href=\"UTD.htm?4/53/4955\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef87859 \" href=\"UTD.htm?13/62/14318\">",
"       table 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      In some cases, people do need special sleep tests, such as &ldquo;polysomnography&rdquo; or &ldquo;actigraphy.&rdquo;",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Polysomnography &ndash; Polysomnography is a test that usually lasts all night and that is done in a sleep lab. During the test, monitors are attached to your body to record movement, brain activity, breathing, and other body functions.",
"       </li>",
"       <li>",
"        Actigraphy &ndash; Actigraphy records activity and movement with a monitor or motion detector that is usually worn on the wrist. The test is done at home, over several days and nights. It will record how much you actually sleep and when.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17011140\">",
"      <span class=\"h1\">",
"       What can I do to improve my insomnia?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can follow good &ldquo;sleep hygiene.&rdquo; That means that you:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Sleep only long enough to feel rested and then get out of bed",
"       </li>",
"       <li>",
"        Go to bed and get up at the same time every day",
"       </li>",
"       <li>",
"        Do not try to force yourself to sleep. If you can't sleep, get out of bed and try again later.",
"       </li>",
"       <li>",
"        Have coffee, tea, and other foods that have caffeine only in the morning",
"       </li>",
"       <li>",
"        Avoid alcohol in the late afternoon, evening, and bedtime",
"       </li>",
"       <li>",
"        Avoid smoking, especially in the evening",
"       </li>",
"       <li>",
"        Keep your bedroom dark, cool, quiet, and free of reminders of work or other things that cause you stress",
"       </li>",
"       <li>",
"        Solve problems you have before you go to bed",
"       </li>",
"       <li>",
"        Exercise several days a week, but not right before bed",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Other things that can improve sleep include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Relaxation therapy, in which you focus on relaxing all the muscles in your body 1 by 1",
"       </li>",
"       <li>",
"        Working with a counselor or psychologist to deal with the problems that might be causing poor sleep",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17011217\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If you have insomnia, and it is troubling you, see your doctor or nurse. He or she might have suggestions on how to fix the problem.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17011147\">",
"      <span class=\"h1\">",
"       Are there medicines to help me sleep?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes, there are medicines to help with sleep. But you should try them only after you try the techniques described above. You also should not use sleep medicines every night for long periods of time. Otherwise, you can become dependent on them for sleep.",
"     </p>",
"     <p>",
"      Insomnia is sometimes caused by mental health problems, such as depression or anxiety. If that's the case for you, you might benefit from an antidepressant rather than a sleep aid. Antidepressants often improve sleep and can help with other worries, too.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17011154\">",
"      <span class=\"h1\">",
"       Can I use alcohol to help me sleep?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No, do not use alcohol as a sleep aid. Even though alcohol makes you sleepy at first, it disrupts sleep later in the night.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17011264\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/29/20946?source=see_link\">",
"       Patient information: Restless legs syndrome (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/4/38978?source=see_link\">",
"       Patient information: Daytime sleepiness (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/9/19602?source=see_link\">",
"       Patient information: Jet lag (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/5/35921?source=see_link\">",
"       Patient information: What is a sleep study? (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?2/16/2306?source=see_link\">",
"       Patient information: Insomnia (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/24/28035?source=see_link\">",
"       Patient information: Insomnia treatments (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?21/58/22434?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16177 Version 4.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-95F309B6B5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22434=[""].join("\n");
var outline_f21_58_22434=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17011166\">",
"      What is insomnia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17011181\">",
"      What are the symptoms of insomnia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17011190\">",
"      Are there tests I should have?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17011140\">",
"      What can I do to improve my insomnia?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17011217\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17011147\">",
"      Are there medicines to help me sleep?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17011154\">",
"      Can I use alcohol to help me sleep?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17011264\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16177\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/53/4955\">",
"      Consensus Sleep Diary",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_table\" href=\"UTD.htm?13/62/14318\">",
"       Consensus Sleep Diary Instructions",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/4/38978?source=related_link\">",
"      Patient information: Daytime sleepiness (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/16/2306?source=related_link\">",
"      Patient information: Insomnia (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/24/28035?source=related_link\">",
"      Patient information: Insomnia treatments (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/9/19602?source=related_link\">",
"      Patient information: Jet lag (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/29/20946?source=related_link\">",
"      Patient information: Restless legs syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/5/35921?source=related_link\">",
"      Patient information: What is a sleep study? (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_58_22435="Equipment for vacuum delivery";
var content_f21_58_22435=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55535&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55535&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Vacuum delivery equipment",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Aron Schuftan, MD. &copy; Aron Schuftan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22435=[""].join("\n");
var outline_f21_58_22435=null;
var title_f21_58_22436="Acral erythema";
var content_f21_58_22436=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F77501&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F77501&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acral erythema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 306px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Acral erythema of the hand.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Payne AS, Jones WD, Weiss RB. Dermatologic toxicity of chemotherapeutic agents. Semin Oncol 2006; 33:86. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22436=[""].join("\n");
var outline_f21_58_22436=null;
var title_f21_58_22437="Ivacaftor: Drug information";
var content_f21_58_22437=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ivacaftor: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/43/8885?source=see_link\">",
"    see \"Ivacaftor: Pediatric drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?30/1/30740?source=see_link\">",
"    see \"Ivacaftor: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F13764717\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Kalydeco&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F15801070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Kalydeco&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F13760356\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Cystic Fibrosis Transmembrane Conductance Regulator Potentiator",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F13764869\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Cystic fibrosis:",
"     </b>",
"     Oral: 150 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Dosage adjustment for ivacaftor with concomitant medications:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     CYP3A4 strong inhibitors (eg, ketoconazole, itraconazole, posaconazole, voriconazole, clarithromycin, telithromycin): 150 mg twice",
"     <b>",
"      weekly",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     CYP3A4 moderate inhibitors (eg, erythromycin, fluconazole): 150 mg once daily",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F13764868\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/43/8885?source=see_link\">",
"      see \"Ivacaftor: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Cystic fibrosis:",
"     </b>",
"     Children &ge;6 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Dosage adjustment for ivacaftor with concomitant medications:",
"     </i>",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F13764850\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;30 mL/minute: No dosage adjustment necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;30 mL/minute: No dosage adjustment provided in manufacturer's labeling (not studied); use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F13764849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Mild impairment (Child-Pugh class A): No dosage adjustment necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Moderate impairment (Child-Pugh class B): 150 mg once daily.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Severe impairment (Child-Pugh class C): Has not been studied; use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     U.S. labeling: Initial: 150 mg once daily or less frequently.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Canadian labeling: Initial: 150 mg once every other day; adjust for tolerance and/or response.",
"    </p>",
"   </div>",
"   <div class=\"block dot drugH1Div\" id=\"F13764848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adjustment for Toxicity",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     ALT or AST &gt;5 times ULN: Hold ivacaftor; may resume if elevated transaminases resolved and after assessing benefits vs risks of continued treatment.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F13764950\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kalydeco&trade;: 150 mg",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F13764878\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Administer with high-fat-containing foods (eg, butter, cheese pizza, eggs, peanut butter).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F13760272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of cystic fibrosis (CF) in patients who have a G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Not effective in patients with CF who are homozygous for the F508del mutation in the CTFR gene",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F13765398\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Headache (4% to 24%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Rash (10% to 13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Abdominal pain (16%), diarrhea (13%), nausea (10% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Oropharyngeal pain (22%), upper respiratory tract infection (16% to 22%), nasal congestion (16% to 20%), nasopharyngitis (15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Dizziness (5% to 9%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Acne (4% to 7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Endocrine &amp; metabolic: Hyperglycemia (4% to 7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hepatic: Transaminases increased (4% to 7%; &gt;5 x ULN: 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Arthralgia (4% to 7%), musculoskeletal chest pain (4% to 7%), myalgia (4% to 7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Pharyngeal erythema (4% to 7%), pleuritic chest pain (4% to 7%), rhinitis (4% to 7%), sinus congestion (4% to 7%), wheezing (4% to 7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Miscellaneous: Bacteria in sputum (4% to 7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% (Limited to important or life-threatening): Hypoglycemia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F13764722\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications listed in the manufacturer's U.S. labeling.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:0em;\">",
"     Canadian labeling: Hypersensitivity to ivacaftor or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F13764723\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Cataracts: Have been observed in animal studies using juvenile rats exposed to ivacaftor (at doses approximately one-tenth the MRHD); cataracts have not been observed in studies involving older animals. It is unknown if this potential concern seen in animals studies is relevant to humans.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hepatic effects: May increase hepatic transaminases; monitor liver function; temporarily discontinue treatment if ALT or AST &gt;5 times ULN.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hepatic impairment: Use with caution; dosage adjustment recommended in patients with moderate-to-severe (Child-Pugh class B or C) impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; High potential for interactions: Ivacaftor efficacy may be reduced by strong CYP3A4 inducers (eg, rifampin, St John&rsquo;s wort); avoid concomitant use. Ivacaftor dose reduction recommended with moderate or strong CYP3A4 inhibitors (eg, erythromycin, ketoconazole). Ivacaftor may inhibit CYP3A and P-gp substrates (eg, digoxin, cyclosporine); use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Appropriate use: Avoid use in patients homozygous for the CFTR gene F508del mutation (not effective).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13769023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2C8 (weak), CYP2C9 (weak), CYP3A4 (weak), P-glycoprotein",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F13769021\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Colchicine. Colchicine distribution into certain tissues (e.g., brain) may also be increased.  Management: Colchicine is contraindicated in patients with impaired renal or hepatic function who are also receiving a p-glycoprotein inhibitor.  In those with normal renal and hepatic function, reduce colchicine dose as directed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May decrease the serum concentration of Ivacaftor.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May increase the serum concentration of Ivacaftor. Management: Decrease ivacaftor dose to 150 mg daily in patients also receiving moderate CYP3A4 inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May increase the serum concentration of Ivacaftor. Management: Decrease ivacaftor dose to 150 mg twice a week in patients also receiving strong CYP3A4 inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Substrates: Ivacaftor may increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: P-glycoprotein/ABCB1 Inhibitors may increase serum concentrations of the active metabolite(s) of Dabigatran Etexilate.  Management: Dabigatran dose reductions may be needed.  Specific recommendations vary considerably according to US vs Canadian labeling, specific P-gp inhibitor, renal function, and indication for dabigatran treatment.  Refer to full monograph or dabigatran labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Everolimus: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Everolimus.  Management: Everolimus dose reductions are required for patients being treated for subependymal giant cell astrocytoma or renal cell carcinoma.  See prescribing information for specific dose adjustment and monitoring recommendations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Grapefruit Juice: May increase the serum concentration of Ivacaftor.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Substrates: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pomalidomide: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Pomalidomide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prucalopride: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Prucalopride.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Rivaroxaban.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Silodosin: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Silodosin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     St Johns Wort: May decrease the serum concentration of Ivacaftor.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topotecan: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Topotecan.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     VinCRIStine (Liposomal): P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of VinCRIStine (Liposomal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F13764818\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Food: Ivacaftor serum concentrations may be increased when taken with grapefruit or Seville oranges. Management: Avoid concurrent use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herb/Nutraceutical: St John&rsquo;s wort may decrease ivacaftor serum concentrations. Management: Avoid concurrent use.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F13764718\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13764719\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F13764720\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13764721\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Although human data is not available, excretion of ivacaftor into breast milk is expected.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F13764832\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Take with high-fat-containing foods (eg, butter, cheese pizza, eggs, peanut butter). Avoid grapefruit or Seville oranges.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322932\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Kalydeco Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     150 mg (60): $30723.60",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F13764892\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CF mutation test (prior to therapy initiation if G551D mutation status unknown); ALT/AST at baseline, every 3 months for 1 year, then annually thereafter or as clinically indicated; FEV",
"     <sub>",
"      1",
"     </sub>",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F13764821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Potentiates epithelial cell chloride ion transport of defective (G551D mutant) cell-surface CFTR protein thereby improving the regulation of salt and water absorption and secretion in various tissues (eg, lung, gastrointestinal tract).",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F13764823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of action: FEV",
"     <sub>",
"      1",
"     </sub>",
"     increased, sweat chloride decreased within ~2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Variable; increased (by two- to fourfold) with fatty foods",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 353 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: ~99%; primarily to alpha",
"     <sub>",
"      1",
"     </sub>",
"     acid glycoprotein, albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Hepatic; extensive via CYP3A4; forms 2 major metabolites (M1 [active; 1/6 potency] and M6 [inactive])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: ~12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak: ~4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Feces (88%, 65% of administered dose as metabolites); urine (minimal, as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Accurso FJ, Rowe SM, Clancy JP, et al, &ldquo;Effect of VX-770 in Persons With Cystic Fibrosis and the G551D-CFTR Mutation,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2010, 363(21):1991-2003.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/58/22437/abstract-text/21083385/pubmed\" id=\"21083385\" target=\"_blank\">",
"        21083385",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ramsey BW, Davies J, McElvaney NG, et al, &ldquo;A CFTR Potentiator in Patients With Cystic Fibrosis and the G551D Mutation,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2011, 365(18):1663-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/58/22437/abstract-text/22047557/pubmed\" id=\"22047557\" target=\"_blank\">",
"        22047557",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 17144 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-1FB45B5B38-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22437=[""].join("\n");
var outline_f21_58_22437=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764717\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15801070\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13760356\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764869\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764868\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764850\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764849\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764848\">",
"      Dosing: Adjustment for Toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764950\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764878\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13760272\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13765398\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764722\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764723\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13769023\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13769021\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764818\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764718\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764719\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764720\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764721\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764832\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322932\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764892\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764821\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13764823\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/17144\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/17144|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?30/1/30740?source=related_link\">",
"      Ivacaftor: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/43/8885?source=related_link\">",
"      Ivacaftor: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_58_22438="Hydrochlorothiazide and spironolactone: Drug information";
var content_f21_58_22438=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Hydrochlorothiazide and spironolactone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?25/5/25685?source=see_link\">",
"    see \"Hydrochlorothiazide and spironolactone: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/28/22982?source=see_link\">",
"    see \"Hydrochlorothiazide and spironolactone: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F179727\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aldactazide&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F179728\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Aldactazide 25&reg;;",
"     </li>",
"     <li>",
"      Aldactazide 50&reg;;",
"     </li>",
"     <li>",
"      Novo-Spirozine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F179742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Diuretic, Thiazide;",
"     </li>",
"     <li>",
"      Selective Aldosterone Blocker",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F179730\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypertension, edema: Oral: Hydrochlorothiazide 12.5-50 mg/day and spironolactone 12.5-50 mg/day; manufacturer labeling states hydrochlorothiazide maximum 200 mg/day, however, usual dose in JNC-7 is 12.5-50 mg/day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F179731\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Consider initiating therapy with the lowest available dose (usual initial doses of hydrochlorothiazide are 12.5-25 mg once daily); increase as necessary.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F179732\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Efficacy of hydrochlorothiazide is limited in patients with Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute; contraindicated in patients with anuria, acute renal insufficiency, significant impairment of renal excretory function, or hyperkalemia.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15897539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use is contraindicated in acute or severe hepatic failure.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F179715\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: Hydrochlorothiazide 25 mg and spironolactone 25 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Aldactazide&reg;:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     25/25: Hydrochlorothiazide 25 mg and spironolactone 25 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     50/50: Hydrochlorothiazide 50 mg and spironolactone 50 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F179703\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F12932309\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer in the morning; administer the last dose of multiple doses before 6 PM unless instructed otherwise.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F179717\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of mild-to-moderate hypertension; treatment of edema in congestive heart failure and nephrotic syndrome, and cirrhosis of the liver accompanied by edema and/or ascites",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F179747\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Aldactazide&reg; may be confused with Aldactone&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F179740\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F179720\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to spironolactone, hydrochlorothiazide or any component of the formulation, thiazides, or sulfonamide-derived drugs; anuria; renal decompensation; hyperkalemia; acute or severe hepatic impairment",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F179706\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Electrolyte disturbances: Hyperkalemia may occur with spironolactone; risk factors include renal dysfunction, diabetes mellitus, and concomitant use of potassium-sparing diuretics, potassium supplements, and/or potassium-containing salts. Use cautiously, if at all, with these agents and monitor potassium closely. Thiazide diuretics may cause hypokalemia, hypochloremic alkalosis, hypomagnesemia, and hyponatremia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gynecomastia: Related to dose and duration of spironolactone therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypersensitivity reactions: Hypersensitivity reactions may occur with hydrochlorothiazide. Risk is increased in patients with a history of allergy or bronchial asthma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ocular effects: Hydrochlorothiazide may cause acute transient myopia and acute angle-closure glaucoma, typically occurring within hours to weeks following initiation; discontinue therapy immediately in patients with acute decreases in visual acuity or ocular pain. Risk factors may include a history of sulfonamide or penicillin allergy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Photosensitivity: Photosensitization may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sulfa allergy: Chemical similarities are present among sulfonamides, sulfonylureas, carbonic anhydrase inhibitors, thiazides, and loop diuretics (except ethacrynic acid). Use in patients with sulfonamide allergy is specifically contraindicated in product labeling, however, a risk of cross-reaction exists in patients with allergy to any of these compounds; avoid use when previous reaction has been severe. Discontinue if signs of hypersensitivity are noted.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Tumorigenic:",
"     <b>",
"      [U.S. Boxed Warning]: Spironolactone shown to be a tumorigen in chronic toxicity animal studies. Avoid unnecessary use.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use hydrochlorothiazide with caution in patients with prediabetes or diabetes mellitus; may see a change in glucose control.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gout: In certain patients with a history of gout, a familial predisposition to gout, or chronic renal failure, gout can be precipitated by hydrochlorothiazide.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use caution in patients with severe hepatic impairment; in cirrhosis, avoid electrolyte and acid/base imbalances that might lead to hepatic encephalopathy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hypercalcemia: Thiazide diuretics may decrease renal calcium excretion; consider avoiding use in patients with hypercalcemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypercholesterolemia: Use with caution in patients with moderate or high cholesterol concentrations; increased cholesterol and triglyceride levels have been reported with thiazides.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Parathyroid disease: Thiazide diuretics reduce calcium excretion; pathologic changes in the parathyroid glands with hypercalcemia and hypophosphatemia have been observed with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Avoid hydrochlorothiazide in severe renal disease (ineffective). Spironolactone may cause hyperkalemia in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Systemic lupus erythematosus (SLE): Hydrochlorothiazide can cause SLE exacerbation or activation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use:",
"     <b>",
"      [U.S. Boxed Warning] Fixed-dose combination drugs should not be used in the initial therapy for edema or hypertension.",
"     </b>",
"     These conditions require individual dose titration.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F179710\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Potassium-Sparing Diuretics may enhance the hyperkalemic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: Thiazide Diuretics may enhance the hypotensive effect of ACE Inhibitors. Specifically, postural hypotension which can accompany ACE Inhibitor initiation. Thiazide Diuretics may enhance the nephrotoxic effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): May enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alfuzosin: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Allopurinol: Thiazide Diuretics may enhance the potential for allergic or hypersensitivity reactions to Allopurinol. Thiazide Diuretics may increase the serum concentration of Allopurinol. Specifically, Thiazide Diuretics may increase the concentration of Oxypurinol, an active metabolite of Allopurinol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists: Spironolactone may diminish the vasoconstricting effect of Alpha-/Beta-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amifostine: Antihypertensives may enhance the hypotensive effect of Amifostine.  Management: When amifostine is used at chemotherapy doses, antihypertensive medications should be withheld for 24 hours prior to amifostine administration. If antihypertensive therapy can not be withheld, amifostine should not be administered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ammonium Chloride: Potassium-Sparing Diuretics may enhance the adverse/toxic effect of Ammonium Chloride. Specifically the risk of systemic acidosis.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Analgesics (Opioid): May enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Angiotensin II Receptor Blockers: May enhance the hyperkalemic effect of Potassium-Sparing Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidiabetic Agents: Thiazide Diuretics may diminish the therapeutic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antihypertensives: May enhance the hypotensive effect of other Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May enhance the orthostatic hypotensive effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benazepril: Hydrochlorothiazide may enhance the hypotensive effect of Benazepril. Hydrochlorothiazide may enhance the nephrotoxic effect of Benazepril. Benazepril may decrease the serum concentration of Hydrochlorothiazide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta2-Agonists: May enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bile Acid Sequestrants: May decrease the absorption of Thiazide Diuretics. The diuretic response is likewise decreased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Salts: Thiazide Diuretics may decrease the excretion of Calcium Salts. Continued concomitant use can also result in metabolic alkalosis.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: Thiazide Diuretics may enhance the adverse/toxic effect of CarBAMazepine. Specifically, there may be an increased risk for hyponatremia.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: Potassium-Sparing Diuretics may diminish the therapeutic effect of Cardiac Glycosides. In particular, the inotropic effects of digoxin appear to be diminished. Potassium-Sparing Diuretics may increase the serum concentration of Cardiac Glycosides. This particular effect may be unique to Spironolactone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Orally Inhaled): May enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Potassium-Sparing Diuretics may enhance the hyperkalemic effect of CycloSPORINE (Systemic).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Digoxin: Spironolactone may increase the serum concentration of Digoxin. Spironolactone (and/or its metabolites) may also interfere with the assays used to determine Digoxin concentrations, falsely increasing or decreasing Digoxin concentrations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dofetilide: Thiazide Diuretics may enhance the QTc-prolonging effect of Dofetilide. Thiazide Diuretics may increase the serum concentration of Dofetilide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Drospirenone: May enhance the hyperkalemic effect of Potassium-Sparing Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eplerenone: May enhance the hyperkalemic effect of Potassium-Sparing Diuretics. Management: This combination is contraindicated in patients receiving eplerenone for treatment of hypertension.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypertensive Properties): May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypotensive Properties): May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypotensive Agents: May enhance the adverse/toxic effect of other Hypotensive Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Licorice: May enhance the hypokalemic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Thiazide Diuretics may decrease the excretion of Lithium.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mitotane: Spironolactone may diminish the therapeutic effect of Mitotane.  Management: Consideration should be given to discontinuing spironolactone prior to initiating mitotane in order to eliminate the risk of therapeutic failure of the mitotane.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): Thiazide Diuretics may enhance the hypercalcemic effect of Multivitamins/Minerals (with ADEK, Folate, Iron).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents (Nondepolarizing): Spironolactone may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents (Nondepolarizing).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nitrofurantoin: May enhance the hyperkalemic effect of Spironolactone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May diminish the therapeutic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May diminish the antihypertensive effect of Potassium-Sparing Diuretics. Nonsteroidal Anti-Inflammatory Agents may enhance the hyperkalemic effect of Potassium-Sparing Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OXcarbazepine: Thiazide Diuretics may enhance the adverse/toxic effect of OXcarbazepine. Specifically, there may be an increased risk for hyponatremia.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphodiesterase 5 Inhibitors: May enhance the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Porfimer: Photosensitizing Agents may enhance the photosensitizing effect of Porfimer.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Salts: May enhance the hyperkalemic effect of Potassium-Sparing Diuretics.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Potassium-Sparing Diuretics may diminish the therapeutic effect of QuiNIDine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RiTUXimab: Antihypertensives may enhance the hypotensive effect of RiTUXimab.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Phosphates: Diuretics may enhance the nephrotoxic effect of Sodium Phosphates. Specifically, the risk of acute phosphate nephropathy may be enhanced.  Management: Consider avoiding this combination by temporarily suspending treatment with diuretics, or seeking alternatives to oral sodium phosphate bowel preparation. If the combination cannot be avoided, hydrate adequately and monitor fluid and renal status.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Systemic): Potassium-Sparing Diuretics may enhance the hyperkalemic effect of Tacrolimus (Systemic).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tolvaptan: May enhance the hyperkalemic effect of Potassium-Sparing Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topiramate: Thiazide Diuretics may enhance the hypokalemic effect of Topiramate. Thiazide Diuretics may increase the serum concentration of Topiramate.  Management: Monitor for increased topiramate levels/adverse effects (e.g., hypokalemia) with initiation/dose increase of a thiazide diuretic. Closely monitor serum potassium concentrations with concomitant therapy. Topiramate dose reductions may be necessary.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Toremifene: Thiazide Diuretics may enhance the hypercalcemic effect of Toremifene.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trimethoprim: May enhance the hyperkalemic effect of Spironolactone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Valsartan: Hydrochlorothiazide may enhance the hypotensive effect of Valsartan. Valsartan may increase the serum concentration of Hydrochlorothiazide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin D Analogs: Thiazide Diuretics may enhance the hypercalcemic effect of Vitamin D Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F179726\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Food: Avoid food with high potassium content and potassium-containing salt substitutes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Avoid natural licorice (causes sodium and water retention and increases potassium loss).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F179711\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F179723\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F179734\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F179722\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Aldactazide Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25-25 mg (100): $142.14",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50-50 mg (100): $262.15",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Spironolactone-HCTZ Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25-25 mg (100): $50.48",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F12932317\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure; serum electrolytes, renal function",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038654\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Adactazida (VE);",
"     </li>",
"     <li>",
"      Aldactazide (IT, PK, TR);",
"     </li>",
"     <li>",
"      Aldazida (BR);",
"     </li>",
"     <li>",
"      Docspirochlor (BE);",
"     </li>",
"     <li>",
"      Ondolen (PT);",
"     </li>",
"     <li>",
"      Slosat (TW);",
"     </li>",
"     <li>",
"      Spironothiazid (CH, DE, SE);",
"     </li>",
"     <li>",
"      Spirozide (KP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F179719\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Chobanian AV, Bakris GL, Black HR, et al, &ldquo;The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2003, 289(19):2560-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/58/22438/abstract-text/12748199/pubmed\" id=\"12748199\" target=\"_blank\">",
"        12748199",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kaplan NM and Sever PS, &ldquo;Combination Therapy: A Key to Comprehensive Patient Care,&rdquo;",
"      <i>",
"       Am J Hypertens",
"      </i>",
"      , 1997, 10(7 Pt 2):127S.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/58/22438/abstract-text/9231887/pubmed\" id=\"9231887\" target=\"_blank\">",
"        9231887",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moser M and Black HR, &ldquo;The Role of Combination Therapy in the Treatment of Hypertension,&rdquo;",
"      <i>",
"       Am J Hypertens",
"      </i>",
"      , 1998, 11(6 Pt 2):73S-8S, 95S-100S.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/58/22438/abstract-text/9655566/pubmed\" id=\"9655566\" target=\"_blank\">",
"        9655566",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National High Blood Pressure Education Program (NHBPEP) Working Group on High Blood Pressure in Children and Adolescents, &ldquo;The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2004, 114(2 Suppl):555-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/58/22438/abstract-text/15286277/pubmed\" id=\"15286277\" target=\"_blank\">",
"        15286277",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pitt B, Zannad F, Remme WJ, et al, &ldquo;The Effect of Spironolactone on Morbidity and Mortality in Patients With Severe Heart Failure. Randomized Aldactone Evaluation Study Investigators,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1999, 341(10):709-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/58/22438/abstract-text/10471456/pubmed\" id=\"10471456\" target=\"_blank\">",
"        10471456",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8755 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-85.214.214.87-89768E4622-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22438=[""].join("\n");
var outline_f21_58_22438=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708903\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179727\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179728\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179742\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179730\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179731\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179732\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15897539\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179715\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179703\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12932309\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179717\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179747\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179740\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179720\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179706\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299456\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179710\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179726\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179711\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179723\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179734\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179722\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12932317\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038654\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179719\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8755\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8755|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?25/5/25685?source=related_link\">",
"      Hydrochlorothiazide and spironolactone: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/28/22982?source=related_link\">",
"      Hydrochlorothiazide and spironolactone: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_58_22439="Alpha thalassemia by gap PCR";
var content_f21_58_22439=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F55893&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F55893&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 607px\">",
"   <div class=\"ttl\">",
"    Alpha thalassemia detection by gap PCR",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 587px; height: 621px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Detection of common alpha thalassemia mutations by gap PCR.",
"    <br>",
"     (A) Diagram depicting the -alpha 3.7 deletion. A1, A2, and A3 show the location of the primers used in the detection of common -alpha 3.7 deletion. The deletion removes the 3' portion of the alpha 2 gene and the 5' portion of the alpha 1 gene (the area between the two diagonal lines in the top portion of the figure), resulting in a hybrid alpha2/alpha1 gene, as shown in the lower portion. This results in the amplification of a 2065 base pair fragment with primers A1 and A3 when deletion is present.",
"     <br>",
"      (B) Table showing the nucleotide (nt) sequence of the primers A1, A2, and A3 and their positions (location) in the alpha globin gene cluster on the reference sequence HUMHBB.",
"      <br>",
"       (C) Detection of the common -alpha 3.7 deletion by gap PCR. Lanes 1 and 8: DNA size markers (1 kb ladder). Lanes 2, 4, and 6 use primers (A1 and A2) for the normal alpha2 gene, while lanes 3, 5, and 7 use primers (A1 and A3) to detect the hybrid gene. Lanes 2 and 3: heterozygous -alpha 3.7 deletion; 1789 bp fragment is generated by the normal control, located on the alpha 2 gene in trans chromosome; 2065 bp fragment is generated by the deletion. Lanes 4 and 5: individual with homozygous deletion; note that there is no amplification of the 1789 bp fragment (lane 4) indicating the absence of the normal gene. Lanes 6 and 7: individual with normal alpha chains; note that there is no amplification of the 2065 bp fragment (lane 7) indicating that there is no -alpha 3.7 deletion (hence the presence of only the 1789 bp fragment in lane 6).",
"       <div class=\"footnotes\">",
"        PCR: polymerase chain reaction.",
"       </div>",
"       <div class=\"reference\">",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22439=[""].join("\n");
var outline_f21_58_22439=null;
var title_f21_58_22440="Seizures in patients undergoing hemodialysis";
var content_f21_58_22440=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Seizures in patients undergoing hemodialysis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/58/22440/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/58/22440/contributors\">",
"     Yousri M Barri, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/58/22440/contributors\">",
"     Thomas A Golper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/58/22440/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/58/22440/contributors\">",
"     Jeffrey S Berns, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/58/22440/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/58/22440/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/58/22440/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seizures are not uncommon in patients undergoing hemodialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/1\">",
"     1",
"    </a>",
"    ]. Since they are more frequent in those who require acute dialysis for a severe uremic state, the current trend toward earlier initiation of dialysis has resulted in a lower incidence of seizures among these patients.",
"   </p>",
"   <p>",
"    Seizure activity generally tends to occur during or shortly after the dialysis procedure because of the hemodynamic and biochemical changes associated with the process [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/1\">",
"     1",
"    </a>",
"    ]. Preventive measures should therefore be initiated in patients with predisposing factors, such as extreme uremia or severe electrolyte abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the causes and treatment of seizures in dialysis patients. The management of seizures in patients without renal failure and a review of the acute complications which may occur during dialysis are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=see_link\">",
"     \"Overview of the management of epilepsy in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/9/8343?source=see_link\">",
"     \"Acute complications during hemodialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CAUSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the causes of seizures are similar in those with and without renal failure. However, some are specifically related to patients with uremia:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Uremic encephalopathy",
"     </li>",
"     <li>",
"      Dialysis disequilibrium syndrome",
"     </li>",
"     <li>",
"      Drugs, such as erythropoietin, carbapenem and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/36/41542?source=see_link\">",
"       ertapenem",
"      </a>",
"     </li>",
"     <li>",
"      Hemodynamic instability, whether hypotension or hypertension",
"     </li>",
"     <li>",
"      Cerebrovascular disease, such as hypertensive encephalopathy, infarction, hemorrhage, and subdural hematoma",
"     </li>",
"     <li>",
"      Dialysis dementia due to aluminum intoxication",
"     </li>",
"     <li>",
"      Electrolyte disorders, such as hypercalcemia, hypocalcemia, hypoglycemia, hyperglycemia, hyponatremia, and hypernatremia",
"     </li>",
"     <li>",
"      Alcohol withdrawal (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/61/20441?source=see_link\">",
"       \"Management of moderate and severe alcohol withdrawal syndromes\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Air embolism (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38664?source=see_link\">",
"       \"Air embolism\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These factors, either alone or in combination, may result in severe central nervous system dysfunction. In patients without renal failure, the presence of one such abnormality may be tolerated without seizure. However, since the threshold for seizure is lower among those with uremia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    multiple electrolyte disorders, the addition of another central nervous system (CNS) insult, such as aggressive dialysis, may result in seizure activity.",
"   </p>",
"   <p>",
"    The following sections discuss the more common causes of seizures which are specific for the dialysis population. Some are independent of dialysis, whereas others are a direct complication of the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Uremic encephalopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Central nervous system dysfunction is universally observed among patients with severe untreated uremia. Depending upon the degree and rapidity of onset of renal failure, symptoms may range from irritability and restlessness to seizures, coma, and death. Seizures, which are most often generalized, and CNS dysfunction should abate shortly (within days to weeks) after the initiation of adequate renal replacement therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Dialysis disequilibrium syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The dialysis disequilibrium syndrome (DDS) is a central nervous system disorder that is characterized by neurologic symptoms of varying severity that are thought to be due primarily to cerebral edema. New patients just being started on hemodialysis are at greatest risk, particularly if the BUN is markedly elevated (above 170",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or 60",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    Other predisposing factors include severe metabolic acidosis, older age, pediatric patients, and the presence of other central nervous system disease, such as a preexisting seizure disorder.",
"   </p>",
"   <p>",
"    The classic DDS refers to acute symptoms developing",
"    <strong>",
"     during or immediately",
"    </strong>",
"    after hemodialysis. Early findings include headache, nausea, disorientation, restlessness, blurred vision, and asterixis. More severely affected patients progress to confusion, seizures, coma, and even death. It is now recognized, however, that many milder signs and symptoms associated with dialysis, such as muscle cramps, anorexia, and dizziness developing near the end of a dialysis treatment, are also part of this syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13125?source=see_link\">",
"     \"Dialysis disequilibrium syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The development of the above symptoms during dialysis is strongly suggestive of DDS. Nevertheless, there are a number of other disorders that must be excluded including uremia itself, subdural hematoma, metabolic disturbances (hyponatremia, hypoglycemia), and drug-induced encephalopathy (see below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Erythropoietin",
"    </span>",
"    &nbsp;&mdash;&nbsp;A rapid rise in blood pressure due to the administration of erythropoietin (EPO) may result in hypertensive encephalopathy, which is sometimes accompanied by seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/6\">",
"     6",
"    </a>",
"    ]. The reported incidence has ranged from 2 to 17 percent, with higher rates observed during the first years of drug use when higher than current doses were given [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. There is little evidence of an excessive incidence of seizure in normotensive patients taking erythropoietin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/15/8436?source=see_link\">",
"     \"Hypertension following erythropoietin in chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is not possible to predict in advance who will develop this complication; prodromal symptoms (such as persistent headache or visual disturbances) must be looked for, particularly in previously normotensive individuals in the early weeks and months after the institution of EPO therapy. Hyperperfusion of the cerebral circulation due to a breakdown of cerebral autoregulation may be important in these cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Drugs or toxins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many medications, in addition to erythropoietin, may precipitate seizure activity in hemodialysis patients. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Penicillin and cephalosporin-related antibiotics &mdash; These drugs may cause seizures, particularly when administered at extremely high doses [",
"      <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/9,10\">",
"       9,10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"       Meperidine",
"      </a>",
"      &mdash; Meperidine (Demerol) should be avoided in dialysis patients since it is associated with accumulation of the toxic metabolite normeperidine, thereby increasing neuromuscular instability and risk of seizure. If meperidine is incorrectly administered, emergent hemodialysis may be successful in those with normeperidine neurotoxicity [",
"      <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"       Metoclopramide",
"      </a>",
"      &mdash; Phenothiazines decrease the seizure threshold and may predispose to seizure in susceptible individuals.",
"     </li>",
"     <li>",
"      Ethanol (intoxication or withdrawal)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"       Theophylline",
"      </a>",
"      (usually toxic levels)",
"     </li>",
"     <li>",
"      L-dopa",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       Lithium",
"      </a>",
"      toxicity",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/46/13031?source=see_link\">",
"       Amantadine",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/7/31856?source=see_link\">",
"       Acyclovir",
"      </a>",
"      &mdash; If the dose is not adjusted in patients with renal failure, acyclovir can induce severe neurotoxicity, including seizures, delirium, and coma [",
"      <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/12-14\">",
"       12-14",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29738?source=see_link\">",
"       \"Cytomegalovirus infection in renal transplant recipients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      High doses of intravenous contrast material",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       Carbamazepine",
"      </a>",
"      overdose is associated with seizure and coma and can be treated with high efficiency hemodialysis [",
"      <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Star fruit ingestion, which is associated with severe neurologic dysfunction, including seizures and death [",
"      <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/16,17\">",
"       16,17",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/36/41542?source=see_link\">",
"       Ertapenem",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/18\">",
"       18",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Hemodynamic instability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypotension is a common complication of hemodialysis, occurring most frequently when dialysis is initiated or near its completion [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/4,19,20\">",
"     4,19,20",
"    </a>",
"    ]. When prolonged or severe, it may predispose to seizure, especially if associated with volume removal, osmotic shifts, abnormal cardiac function, or an underlying lesion of the central nervous system.",
"   </p>",
"   <p>",
"    Severe intradialytic hypertension due to reactive vasoconstriction also can potentiate seizure activity in predisposed individuals. The acute increase in blood pressure is secondary to a hyperactive response to hypotension induced by ultrafiltration. This blood pressure response is relatively common. As an example, a rise of more than 30 mmHg in systolic blood pressure was observed one or more times in 57 percent of patients followed for an average period of 11 months [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Cerebrovascular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients on dialysis are at an increased risk of cerebrovascular disease because of accelerated atherosclerosis, older age, and a high incidence of hypertension, diabetes, malnutrition, and hyperlipidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Manifestations include hypertensive encephalopathy, transient ischemic attacks, cerebral infarcts, intracerebral hemorrhage, and subdural hematoma. All these conditions may be associated with seizure activity.",
"   </p>",
"   <p>",
"    Issues surrounding the consequences of a cerebral aneurysm in the dialysis patient with polycystic kidney disease are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/33/30233?source=see_link\">",
"     \"Extrarenal manifestations of autosomal dominant polycystic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Hypertensive encephalopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertensive encephalopathy refers to the presence of signs of cerebral edema caused by breakthrough hyperperfusion from severe and sudden rises in blood pressure. Signs and symptoms of neurologic involvement may include headache, nausea, vomiting, confusion, and mental status abnormalities, including focal or generalized seizures.",
"   </p>",
"   <p>",
"    The initial aim of treatment in the patient with hypertensive encephalopathy is to lower the diastolic pressure with the maximum initial fall in blood pressure not exceeding 25 percent of the presenting value; this goal should be achieved within two to six hours and should not be exceeded in the first 24 hours. This level of blood pressure control will allow gradual healing of the necrotizing vascular lesions. More aggressive hypotensive therapy is both unnecessary and may reduce the blood pressure below the autoregulatory range, possibly leading to ischemic events (such as stroke, angina, or myocardial infarction). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41398?source=see_link\">",
"     \"Malignant hypertension and hypertensive encephalopathy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    With dialysis patients, initial therapy of hypertensive encephalopathy should aim to optimize volume status via fluid removal with dialysis, since volume overload is likely to be causative. If blood pressure remains high despite the attainment of optimal dry weight, parenteral therapy may be necessary, particularly in the setting of clinical cardiac or neurologic involvement. Vasodilators, such as sodium",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21302?source=see_link\">",
"     nitroprusside",
"    </a>",
"    , may be used since the dose of the agent can be titrated easily to the desired blood pressure. The recommended dose of nitroprusside ranges from 0.25 to 10",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per minute, which is titrated to maintain the blood pressure at the desired target. Constant blood pressure monitoring (preferably in an intensive care unit) is required during the infusion. However, patients treated with sodium nitroprusside may require daily dialysis to eliminate the toxic metabolite (thiocyanate, which is normally eliminated by the kidney); the agent should generally not be used for more than 48 hours.",
"   </p>",
"   <p>",
"    An alternative parentally administered drug is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35544?source=see_link\">",
"     labetalol",
"    </a>",
"    , which can be administered by bolus or intravenous infusion. The usual intravenous dose of labetalol is 20 mg (which is administered over two minutes); an additional 20 to 80 mg may be administered at 10 minute intervals to a maximum total dose of 300 mg. Labetalol may also be administered as an intravenous infusion at a rate of two",
"    <span class=\"nowrap\">",
"     mg/minute.",
"    </span>",
"    The drug begins to act within five minutes of administration. Oral antihypertensive medications should be concurrently initiated to shorten the duration of parenteral therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Transient ischemic attacks",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient ischemic attacks (TIA) are defined as temporary neurologic deficits due to ischemia which resolve within a 24 hour period. Their presence enhances the risk of future cerebral infarcts; they are usually associated with carotid artery disease; a common cause is embolization from an atherosclerotic site or an intracardiac source. The clinical presentation of TIA depends upon the vascular territory involved. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/46/40678?source=see_link\">",
"     \"Etiology and clinical manifestations of transient ischemic attack\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    TIAs resulting in seizures can also be precipitated by dialysis-induced hypotension. In this setting, the differential diagnosis includes focal seizure, syncope, vertigo, and migraine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/37/36439?source=see_link\">",
"     \"Differential diagnosis of transient ischemic attack and stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Cerebral infarction and hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebral infarcts may develop secondary to thrombosis or embolism, with the neurologic abnormalities determined by the size and location of the lesion. Dialysis patients appear to be at markedly increased risk of stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a survey from Japan, patients on maintenance dialysis had a relative risk of 5.2 for stroke, 10.7 for cerebral hemorrhage, and 4.0 for subarachnoid hemorrhage compared to normal subjects [",
"      <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a second study from the United States, dialysis patients had a relative risk of ischemic and hemorrhagic stroke of 4.3 to 10.1 and 4.1 to 6.7, respectively, compared with the normal population [",
"      <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/26\">",
"       26",
"      </a>",
"      ]; the range in relative risk varied with gender and ethnicity.",
"     </li>",
"     <li>",
"      In a third study from Japan, infarctions were observed to more frequently involve the vertebrobasilar system than a control group with stroke and normal renal function [",
"      <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Large infarcts may be associated with edema or hemorrhage; the latter may be more likely to occur with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    administration during dialysis or among those with elevated blood pressures. Large hemorrhages can displace midline structures and compromise vital centers in the brainstem. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/17/40216?source=see_link\">",
"     \"Clinical diagnosis of stroke subtypes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Important strategies to avoid worsening of the neurologic deficit include better blood pressure control and the elimination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    during dialysis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/57/17305?source=see_link\">",
"     \"Antihypertensive therapy to prevent recurrent stroke or transient ischemic attack\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Subdural hematoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;A subdural hematoma can occur spontaneously in hemodialysis patients or after routine dialysis treatment or trauma to the head. The initial presentation may include mental status change, confusion, headache, seizure, or dementia which may be similar in symptomatology to that associated with dialysis disequilibrium syndrome, hypertensive encephalopathy, or dialysis-associated dementia [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A suspected diagnosis of subdural hematoma can be easily confirmed by CT scan; the disorder usually requires surgical treatment. To avoid recurrence, hemodialysis should be performed without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    for 7 to 10 days or peritoneal dialysis should be used temporarily [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Dialysis dementia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dialysis dementia is a progressive neurologic disorder observed exclusively in dialysis patients. The presence of high concentrations of aluminum in plasma and in the brains of patients with the disorder has strongly implicated aluminum accumulation as the causative factor [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. The incidence of dialysis dementia has markedly declined because of better water treatment and quality control, and the use of non-aluminum containing phosphate binders for the chronic management of hyperphosphatemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/32/29190?source=see_link\">",
"     \"Contaminants in water used for hemodialysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The signs and symptoms of dialysis dementia include dyscalculia, dyslexia, dyspraxia, dysgraphia, impaired memory, myoclonic jerks, and seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/31\">",
"     31",
"    </a>",
"    ]. The EEG pattern in affected patients is abnormal, demonstrating paroxysmal multifocal bursts of high amplitude delta activity (four waves per second) with a spike and short waves. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/14/5352?source=see_link\">",
"     \"Aluminum toxicity in end-stage renal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevention of seizures in dialysis patients involves the recognition and amelioration of one or more of the following risk factors:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Uremic encephalopathy",
"     </li>",
"     <li>",
"      Dialysis disequilibrium syndrome",
"     </li>",
"     <li>",
"      Rapid acid-base and osmolality changes with dialysis",
"     </li>",
"     <li>",
"      Hypoxia secondary to volume overload or underlying cardiac or pulmonary disease",
"     </li>",
"     <li>",
"      Hypotension and hemodynamic instability",
"     </li>",
"     <li>",
"      Anticoagulation in the presence of intracranial bleeding",
"     </li>",
"     <li>",
"      Removal of anticonvulsant medications during dialysis",
"     </li>",
"     <li>",
"      Hypertensive crisis which may be induced by EPO therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Uremic encephalopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;An absolute indication for the initiation of dialysis includes progressive uremic encephalopathy, including confusion, seizures, and asterixis. However, since these findings may be life-threatening, it is now appreciated that the initiation of dialysis prior to the onset of these findings does not place the patient in unnecessary jeopardy and may prevent the occurrence of CNS dysfunction, including seizures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Dialysis disequilibrium syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prevention is the mainstay of therapy in the DDS, particularly in new dialysis patients who are at highest risk. The initial dialyses should be gentle, but repeated frequently. The aim is a",
"    <strong>",
"     gradual reduction",
"    </strong>",
"    in BUN, which will be protective but may not prevent mild symptoms such as headache and malaise.",
"   </p>",
"   <p>",
"    We begin with low blood flow rates (150 to 200",
"    <span class=\"nowrap\">",
"     mL/min),",
"    </span>",
"    short dialysis (about two hours), a small surface area dialyzer (0.9 to 1.2 m2), and concurrent rather than countercurrent blood and dialysate flow. The intensity of dialysis is gradually increased over subsequent days as the uremia is controlled to reach blood flow rates of 300 to 400",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    and a dialysis duration of four hours.",
"   </p>",
"   <p>",
"    Other preventive measures include the use of bicarbonate dialysate, and a dialysate glucose concentration of 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (11.1",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    in diabetic patients to prevent hypoglycemia. We also recommend prophylactic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    (1000 mg loading dose followed by 300",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    until uremia is controlled)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the administration of 12.5 g of hypertonic",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    intravenously every hour of dialysis in",
"    <strong>",
"     high-risk patients",
"    </strong>",
"    with marked azotemia (BUN above 150 to 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [54 to 71",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    or an underlying alteration in mental status. Additional related issues are discussed separately in appropriate topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13125?source=see_link\">",
"     \"Dialysis disequilibrium syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Dialyzable antiepileptic drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain antiepileptic medications, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/40/29321?source=see_link\">",
"     phenobarbital",
"    </a>",
"    <strong>",
"     and",
"    </strong>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/14/30952?source=see_link\">",
"     primidone",
"    </a>",
"    , are removed by dialysis and must be supplemented if therapeutic levels are to be maintained. [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/32\">",
"     32",
"    </a>",
"    ]. Fortunately, the more commonly used drugs &mdash;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    , and valproic acid &mdash; are nondialyzable, and require no postdialysis supplementation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=see_link\">",
"     \"Pharmacology of antiepileptic drugs\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Erythropoietin therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;To reduce the frequency of seizures in association with EPO therapy, the following treatment guidelines have been suggested [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The initial weekly dose of EPO should not exceed 150",
"      <span class=\"nowrap\">",
"       units/kg.",
"      </span>",
"     </li>",
"     <li>",
"      The subcutaneous route of administration is preferred, since the intravenous route may more readily stimulate endothelin-1, a potent vasoconstrictor.",
"     </li>",
"     <li>",
"      High risk patients, such as those with hypertension",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a history of seizures, should be closely monitored; in addition, the dose of EPO should be slowly increased among such patients.",
"     </li>",
"     <li>",
"      Patients with severe or uncontrolled hypertension should initially be excluded from EPO therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If seizures have occurred in association with an elevation of blood pressure, EPO therapy can be resumed at a reduced dose of one-third to one-half the previous dose following good blood pressure control; to prevent recurrence, a lower rate of rise in hematocrit in combination with close blood pressure monitoring should be treatment goals. In one study, for example, four of seven patients were restarted on a reduced dose of EPO without seizure recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/15/8436?source=see_link\">",
"     \"Hypertension following erythropoietin in chronic kidney disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Dialysis-induced hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prevention of dialysis-hypotension involves a variety of maneuvers. This is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/32/31240?source=see_link\">",
"     \"Hemodynamic instability during hemodialysis: Overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF SEIZURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The emergency treatment of seizures in the dialysis patient includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Stopping dialysis",
"     </li>",
"     <li>",
"      Securing a patent airway",
"     </li>",
"     <li>",
"      Stabilizing the circulation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Blood should be sampled for serum levels of glucose, calcium, sodium, magnesium and other electrolytes, marked abnormalities of which may suggest the underlying cause of the seizure. Intravenous glucose should be administered if hypoglycemia is suspected, particularly in diabetic patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=see_link\">",
"     \"Overview of the management of epilepsy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If seizures persist, a benzodiazepine should be administered, such as 5 to 10 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    given by slow intravenous push. The dose can be repeated at five minute intervals to a maximum total dose of 20 to 30 mg. If administered, an antidote for diazepam (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/6/41062?source=see_link\">",
"     flumazenil",
"    </a>",
"    ) should always be available if respiratory depression occurs. Initial diazepam therapy may be followed by a loading dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    (10 to 15",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    given at a rate no greater than 50",
"    <span class=\"nowrap\">",
"     mg/min;",
"    </span>",
"    constant electrocardiographic monitoring should be performed during this infusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Metabolism of antiepileptic drugs in renal failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal failure may influence the response to anticonvulsants by altering the distribution, metabolism, and clearance of these drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. Pharmacokinetic studies of antiepileptic drugs in uremic patients are limited. With respect to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    and valproic acid, both drugs are highly protein bound [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]; in patients with renal failure or hypoalbuminemia, displacement from serum proteins occurs with a concomitant increase in the volume of distribution.",
"   </p>",
"   <p>",
"    The clinical importance of this phenomenon is that the patient has the same concentration of free drug in serum at a lower total blood concentration than does the subject with normal renal function. Since most clinical laboratories measure only total concentration of drug in the blood, the importance of the phenomenon is in the proper interpretation of a blood level for these drugs in such patients.",
"   </p>",
"   <p>",
"    A further reduction in protein binding of valproic acid has been observed during hemodialysis. This may be related to the administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    , which is known to activate the enzyme lipoprotein lipase [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data suggest that no change in",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    and valproic acid dosage is required in patients with end-stage renal failure. For phenytoin, the therapeutic range for total drug concentration falls from 10 to 20",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    in subjects with normal renal function to 4 to 10",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    with a plasma creatinine concentration of 10",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (880",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Maintenance therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term therapy with antiepileptic medications may not be required if the patient's seizure is due to a reversible cause. If not, maintenance therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    , or valproic acid can be used to prevent recurrent seizures. Seizures resulting from DDS respond best to benzodiazepines, particularly",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/45/26328?source=see_link\">",
"     clonazepam",
"    </a>",
"    . No dose adjustment is necessary for clonazepam in renal failure; the daily recommended oral dose is 1.5 mg [",
"    <a class=\"abstract\" href=\"UTD.htm?21/58/22440/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Phenytoin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     Phenytoin",
"    </a>",
"    is the most common medication used for the treatment of seizures in dialysis patients. As noted above, the usual loading and maintenance dosages of phenytoin should be administered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=see_link\">",
"     \"Pharmacology of antiepileptic drugs\"",
"    </a>",
"    .) The target blood level for total phenytoin should be in the range of approximately 4 to 10",
"    <span class=\"nowrap\">",
"     mg/L,",
"    </span>",
"    approximately one-half that in subjects with normal function due to the decline in protein binding in uremia. However, because of the uncertainty of the relationship of total concentration to free drug concentration, it is preferable to monitor the free phenytoin concentration. A concentration of 1.0 to 2.5",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    is desirable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1391794\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Seizures are not uncommon in patients undergoing hemodialysis, although the trend toward earlier initiation of dialysis has resulted in a lower incidence. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Causes of seizures in patients undergoing hemodialysis include uremic encephalopathy, dialysis disequilibrium syndrome, the use of certain drugs, hemodynamic instability, cerebrovascular disease, dialysis dementia due to aluminum intoxication, electrolyte disorders, alcohol withdrawal, and air embolism. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Causes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The emergency treatment of seizures in the dialysis patient includes stopping dialysis, securing a patent airway and stabilizing the circulation. Blood should be sampled for serum levels of glucose, calcium, sodium, magnesium and other electrolytes, marked abnormalities of which may suggest the underlying cause of the seizure. Intravenous glucose should be administered if hypoglycemia is suspected, particularly in diabetic patients. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Management of seizures'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=see_link\">",
"       \"Overview of the management of epilepsy in adults\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      If seizures persist, a benzodiazepine should be administered, such as 5 to 10 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"       diazepam",
"      </a>",
"      given by slow intravenous push. The dose can be repeated at five minute intervals to a maximum total dose of 20 to 30 mg. If administered, an antidote for diazepam (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/6/41062?source=see_link\">",
"       flumazenil",
"      </a>",
"      ) should always be available if respiratory depression occurs. Initial diazepam therapy may be followed by a loading dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      (10 to 15",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      given at a rate no greater than 50",
"      <span class=\"nowrap\">",
"       mg/min;",
"      </span>",
"      constant electrocardiographic monitoring should be performed during this infusion. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Phenytoin'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Renal failure may alter the distribution, metabolism, and clearance of antiepileptic drugs including",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      and valproic acid. The change in the volume of distribution of phenytoin decreases the therapeutic range for total drug concentration from 10 to 20",
"      <span class=\"nowrap\">",
"       mg/L",
"      </span>",
"      in subjects with normal renal function to 5 to 10",
"      <span class=\"nowrap\">",
"       mg/L",
"      </span>",
"      with a plasma creatinine concentration of 10",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (880",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"      It is preferable to monitor the free phenytoin concentration. A concentration of 1.0 to 2.5",
"      <span class=\"nowrap\">",
"       mg/L",
"      </span>",
"      is desirable. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Metabolism of antiepileptic drugs in renal failure'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Long-term therapy with antiepileptic medications may not be required if the patient's seizure is due to a reversible cause. If not, maintenance therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"       carbamazepine",
"      </a>",
"      , or valproic acid can be used to prevent recurrent seizures. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Maintenance therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/1\">",
"      Glenn CM, Astley SJ, Watkins SL. Dialysis-associated seizures in children and adolescents. Pediatr Nephrol 1992; 6:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/2\">",
"      Canavese C, Morellini V, Lazzarich E, et al. Seizures and renal failure: is there a link? Nephrol Dial Transplant 2005; 20:2855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/3\">",
"      Arieff AI. Dialysis disequilibrium syndrome: current concepts on pathogenesis and prevention. Kidney Int 1994; 45:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/4\">",
"      Rostand SG, Brunzell JD, Cannon RO 3rd, Victor RG. Cardiovascular complications in renal failure. J Am Soc Nephrol 1991; 2:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/5\">",
"      Rodrigo F, Shideman J, McHugh R, et al. Osmolality changes during hemodialysis. Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol. Ann Intern Med 1977; 86:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/6\">",
"      Beccari M. Seizures in dialysis patients treated with recombinant erythropoietin. Review of the literature and guidelines for prevention. Int J Artif Organs 1994; 17:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/7\">",
"      Edmunds ME, Walls J, Tucker B, et al. Seizures in haemodialysis patients treated with recombinant human erythropoietin. Nephrol Dial Transplant 1989; 4:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/8\">",
"      Strippoli GF, Craig JC, Manno C, Schena FP. Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials. J Am Soc Nephrol 2004; 15:3154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/9\">",
"      Lin CS, Cheng CJ, Chou CH, Lin SH. Piperacillin/tazobactam-induced seizure rapidly reversed by high flux hemodialysis in a patient on peritoneal dialysis. Am J Med Sci 2007; 333:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/10\">",
"      Ferrara N, Abete P, Giordano M, et al. Neurotoxicity induced by Cefepime in a very old hemodialysis patient. Clin Nephrol 2003; 59:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/11\">",
"      Hassan H, Bastani B, Gellens M. Successful treatment of normeperidine neurotoxicity by hemodialysis. Am J Kidney Dis 2000; 35:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/12\">",
"      Davenport A, Goel S, Mackenzie JC. Neurotoxicity of acyclovir in patients with end-stage renal failure treated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1992; 20:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/13\">",
"      Almond MK, Fan S, Dhillon S, et al. Avoiding acyclovir neurotoxicity in patients with chronic renal failure undergoing haemodialysis. Nephron 1995; 69:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/14\">",
"      Helld&eacute;n A, Odar-Cederl&ouml;f I, Diener P, et al. High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study. Nephrol Dial Transplant 2003; 18:1135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/15\">",
"      Schuerer DJ, Brophy PD, Maxvold NJ, et al. High-efficiency dialysis for carbamazepine overdose. J Toxicol Clin Toxicol 2000; 38:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/16\">",
"      Chang JM, Hwang SJ, Kuo HT, et al. Fatal outcome after ingestion of star fruit (Averrhoa carambola) in uremic patients. Am J Kidney Dis 2000; 35:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/17\">",
"      Neto MM, da Costa JA, Garcia-Cairasco N, et al. Intoxication by star fruit (Averrhoa carambola) in 32 uraemic patients: treatment and outcome. Nephrol Dial Transplant 2003; 18:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/18\">",
"      Seto AH, Song JC, Guest SS. Ertapenem-associated seizures in a peritoneal dialysis patient. Ann Pharmacother 2005; 39:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/19\">",
"      Heber ME, Lahiri A, Thompson D, Raftery EB. Baroreceptor, not left ventricular, dysfunction is the cause of hemodialysis hypotension. Clin Nephrol 1989; 32:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/20\">",
"      Campese VM, Romoff MS, Levitan D, et al. Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 1981; 20:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/21\">",
"      Benna P, Lacquaniti F, Triolo G, et al. Acute neurologic complications of hemodialysis. Study of 14,000 hemodialyses in 103 patients with chronic renal failure. Ital J Neurol Sci 1981; 2:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/22\">",
"      Abuelo, JG, Shemin, D, Chazan, JA. Acute symptoms produced by hemodialysis: A review of their causes and associations. Semin Dial 1993; 6:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/23\">",
"      Noriega-Sanchez A, Martinez-Maldonado M, Haiffe RM. Clinical and electroencephalographic changes in progressive uremic encephalopathy. Neurology 1978; 28:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/24\">",
"      Seliger SL, Gillen DL, Tirschwell D, et al. Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol 2003; 14:2623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/25\">",
"      Iseki K, Kinjo K, Kimura Y, et al. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 1993; 44:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/26\">",
"      Seliger SL, Gillen DL, Longstreth WT Jr, et al. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 2003; 64:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/27\">",
"      Toyoda K, Fujii K, Fujimi S, et al. Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis 2005; 45:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/28\">",
"      Nix WA. Coincidence of uremic and hypertensive encephalopathy with chronic subdural hematoma under hemodialysis. Case report. J Neurosurg Sci 1983; 27:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/29\">",
"      Tietjen DP, Moore J Jr, Gouge SF. Hemodialysis-associated acute subdural hematoma. Interim management with peritoneal dialysis. Am J Nephrol 1987; 7:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/30\">",
"      Alfrey AC, LeGendre GR, Kaehny WD. The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med 1976; 294:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/31\">",
"      Mahoney CA, Arieff AI. Uremic encephalopathies: clinical, biochemical, and experimental features. Am J Kidney Dis 1982; 2:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/32\">",
"      Porto I, John EG, Heilliczer J. Removal of phenobarbital during continuous cycling peritoneal dialysis in a child. Pharmacotherapy 1997; 17:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/33\">",
"      Kandrotas RJ, Love JM, Gal P, Oles KS. The effect of hemodialysis and hemoperfusion on serum valproic acid concentration. Neurology 1990; 40:1456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/34\">",
"      Kandrotas RJ, Oles KS, Gal P, Love JM. Carbamazepine clearance in hemodialysis and hemoperfusion. DICP 1989; 23:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/35\">",
"      Reidenberg MM. The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function. Am J Med 1977; 62:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/36\">",
"      Israni RK, Kasbekar N, Haynes K, Berns JS. Use of antiepileptic drugs in patients with kidney disease. Semin Dial 2006; 19:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/37\">",
"      Depner TA, Gulyassy PF. Plasma protein binding in uremia: extraction and characterization of an inhibitor. Kidney Int 1980; 18:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/38\">",
"      Reynolds F, Ziroyanis PN, Jones NF, Smith SE. Salivary phenytoin concentrations in epilepsy and in chronic renal failure. Lancet 1976; 2:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/39\">",
"      Bruni J, Wang LH, Marbury TC, et al. Protein binding of valproic acid in uremic patients. Neurology 1980; 30:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/58/22440/abstract/40\">",
"      Andr&eacute; M, Boutroy MJ, Dubruc C, et al. Clonazepam pharmacokinetics and therapeutic efficacy in neonatal seizures. Eur J Clin Pharmacol 1986; 30:585.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1894 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.111.122.2-E64CDCC3B7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22440=[""].join("\n");
var outline_f21_58_22440=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1391794\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CAUSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Uremic encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Dialysis disequilibrium syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Erythropoietin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Drugs or toxins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Hemodynamic instability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Cerebrovascular disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Hypertensive encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Transient ischemic attacks",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Cerebral infarction and hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Subdural hematoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Dialysis dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Uremic encephalopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Dialysis disequilibrium syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Dialyzable antiepileptic drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Erythropoietin therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Dialysis-induced hypotension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      MANAGEMENT OF SEIZURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Metabolism of antiepileptic drugs in renal failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Maintenance therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Phenytoin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1391794\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/9/8343?source=related_link\">",
"      Acute complications during hemodialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38664?source=related_link\">",
"      Air embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/14/5352?source=related_link\">",
"      Aluminum toxicity in end-stage renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/57/17305?source=related_link\">",
"      Antihypertensive therapy to prevent recurrent stroke or transient ischemic attack",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/17/40216?source=related_link\">",
"      Clinical diagnosis of stroke subtypes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/32/29190?source=related_link\">",
"      Contaminants in water used for hemodialysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29738?source=related_link\">",
"      Cytomegalovirus infection in renal transplant recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13125?source=related_link\">",
"      Dialysis disequilibrium syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/37/36439?source=related_link\">",
"      Differential diagnosis of transient ischemic attack and stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/46/40678?source=related_link\">",
"      Etiology and clinical manifestations of transient ischemic attack",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/33/30233?source=related_link\">",
"      Extrarenal manifestations of autosomal dominant polycystic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/32/31240?source=related_link\">",
"      Hemodynamic instability during hemodialysis: Overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/15/8436?source=related_link\">",
"      Hypertension following erythropoietin in chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41398?source=related_link\">",
"      Malignant hypertension and hypertensive encephalopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/61/20441?source=related_link\">",
"      Management of moderate and severe alcohol withdrawal syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=related_link\">",
"      Overview of the management of epilepsy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=related_link\">",
"      Pharmacology of antiepileptic drugs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_58_22441="Amyloid EM";
var content_f21_58_22441=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F54148&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F54148&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Electron micrograph showing renal amyloidosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph showing expansion of the mesangium by amyloid fibrils, which can measure 7 to 12 nanometers in diameter.&nbsp;The fibrillar appearance is best appreciated at the arrow.&nbsp;These fibrils are smaller than those seen in fibrillary and immunotactoid glomerulonephritis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Electron micrograph of a normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph of a normal glomerular capillary loop showing the fenestrated endothelial cell (Endo), the glomerular basement membrane (GBM), and the epithelial cells with its interdigitating foot processes (arrow). The GBM is thin, and no electron dense deposits are present. Two normal platelets are seen in the capillary lumen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22441=[""].join("\n");
var outline_f21_58_22441=null;
var title_f21_58_22442="Child injury statement A";
var content_f21_58_22442=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74172%7EPEDS%2F81355&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74172%7EPEDS%2F81355&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 493px\">",
"   <div class=\"ttl\">",
"    Child injury statement, page 1",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 473px; height: 637px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hospitals and or states may have specific forms for reporting child abuse and or neglect. The form used by Texas Children's Hospital is shown as an example. When child abuse is reported by a physician, a copy of the written report should be filed in the patient's medical record.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 493px\">",
"   <div class=\"ttl\">",
"    Child injury statement, page 2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 473px; height: 634px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hospitals and or states may have specific forms for reporting child abuse and or neglect. The form used by Texas Children's Hospital is shown as an example. When child abuse is reported by a physician, a copy of the written report should be filed in the patient's medical record.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22442=[""].join("\n");
var outline_f21_58_22442=null;
var title_f21_58_22443="Stillbirth evaluation";
var content_f21_58_22443=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F52278&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F52278&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Indications for special studies during perinatal autopsy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Hydrops fetalis and/or placentitis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Viral cultures (fetus/placenta), request maternal screen",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Kleihaur-Betke",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Fetal blood smear if possible",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Fetal hematocrit if possible",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Freeze liver (at 4 degrees Celcius) for possible metabolic studies",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Consider post-mortem blood spot for standard neonatal screening",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Obtain tissue for karyotype",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Skeletal dysplasias (short limbs, any boney anomaly)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Good radiographs",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Save fresh boney and skeletal muscle for biochemistry",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Obtain tissue for karyotype",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <p>",
"        Consider consultation with the Skeletal Registry at Cedars Sinai Medical Center:",
"       </p>",
"       <p>",
"        (1-800-CEDARS-1 (233-2771)",
"       </p>",
"       <p>",
"        file://www.cedars-sinai.edu/9934.html",
"       </p>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22443=[""].join("\n");
var outline_f21_58_22443=null;
var title_f21_58_22444="Comparison of complement studies in angioedema disorders";
var content_f21_58_22444=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F83098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F83098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Comparison of complement studies in angioedema disorders",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Angiodema disorder",
"       </td>",
"       <td class=\"subtitle1\">",
"        C4*",
"       </td>",
"       <td class=\"subtitle1\">",
"        C1 inhibitor level",
"       </td>",
"       <td class=\"subtitle1\">",
"        C1 inhibitor function",
"       </td>",
"       <td class=\"subtitle1\">",
"        C1q",
"       </td>",
"       <td class=\"subtitle1\">",
"        C3",
"       </td>",
"       <td class=\"subtitle1\">",
"        Other tests",
"        <br/>",
"        (not routinely needed for diagnosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HAE I",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"       <td>",
"        Low",
"        <br/>",
"        (usually &lt;50 percent of normal)",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Genetic testing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HAE II",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"       <td>",
"        Normal or elevated",
"       </td>",
"       <td>",
"        Low",
"        <br/>",
"        (usually &lt;50 percent of normal)",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Genetic testing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HAE III",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Mutations in gene for factor XII detected in some patients",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        AAE",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"       <td>",
"        Normal or low",
"       </td>",
"       <td>",
"        Low",
"        <br/>",
"        (usually &lt;50 percent of normal)",
"       </td>",
"       <td>",
"        Normal or low",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Normal or low",
"       </td>",
"       <td>",
"        Anti-C1 inhibitor antibodies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Idiopathic angioedema",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        Normal",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    HAE: Hereditary angioedema (aka hereditary C1 inhibitor deficiency)",
"    <br>",
"     AAE: Acquired angioedema (aka acquired C1 inhibitor deficiency)",
"     <div class=\"footnotes\">",
"      * In inherited angioedema types I and II, C4 is always low during an attack (with one published exception) and are chronically low in the majority of patients.",
"      <br/>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      There are rare forms of acquired angioedema in which C1q levels are normal. See topic review of acquired C1 inhibitor deficiency for details.",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22444=[""].join("\n");
var outline_f21_58_22444=null;
var title_f21_58_22445="BRCA testing NCCN criteria";
var content_f21_58_22445=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F56222&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F56222&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    National Comprehensive Cancer Network criteria for consideration of BRCA1/2 genetic testing",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        A. Individual from a family with a known deleterious BRCA1/BRCA2 mutation*&bull;&Delta;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        B. Personal history of breast cancer&loz; plus one or more of the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        <ul>",
"         <li>",
"          Diagnosed age &le;45 years",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        <ul>",
"         <li>",
"          Diagnosed age &le;50 years with &ge;1 first, second, or third-degree blood relative with breast cancer &le;50 years and/or &ge;1 first, second, or third-degree blood relative with epithelial ovarian/fallopian tube/primary peritoneal cancer at any age",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        <ul>",
"         <li>",
"          Two breast primaries&sect; when first breast cancer diagnosis occurred &le;50 years",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        <ul>",
"         <li>",
"          Diagnosed &le;60 years with a triple negative breast cancer",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        <ul>",
"         <li>",
"          Diagnosed &le;50 years with a limited family history&Delta;",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        <ul>",
"         <li>",
"          Diagnosed at any age with &ge;2 first, second, or third-degree blood relatives with breast and/or epithelial ovarian/fallopian tube/primary peritoneal cancer at any age",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        <ul>",
"         <li>",
"          Diagnosed at any age with &ge;2 first, second, or third-degree blood relatives with&nbsp;pancreatic cancer at any age",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        <ul>",
"         <li>",
"          First, second, or third-degree male blood relative with breast cancer",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        <ul>",
"         <li>",
"          For an individual of ethnicity associated with higher mutation frequency (eg, Ashkenazi Jewish), no additional family history may be required&yen;",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        C. Personal history of epithelial ovarian/fallopian tube/primary peritoneal cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        D. Personal history of male breast cancer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        E. Personal history of pancreatic cancer at any age with &ge;2 first, second, or third-degree blood relatives with breast and/or ovarian cancer and/or pancreatic cancer at any age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        F. Family history only:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        <ul>",
"         <li>",
"          First or second-degree blood relative meeting any of the above criteria",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        <ul>",
"         <li>",
"          Third-degree blood relative with breast cancer&loz; and/or ovarian/fallopian tube/primary peritoneal cancer with &ge;2 first, second, or third-degree blood relatives with breast cancer (at least one breast cancer &le;50 years) and/or ovarian/fallopian tube/primary peritoneal cancer",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * One or more of these criteria is suggestive of hereditary breast/ovarian cancer syndrome that warrants further personalized risk assessment, genetic counseling, and management. The maternal and paternal sides should be considered independently. Other malignancies reported in some hereditary breast/ovarian cancer syndrome families include prostate and melanoma.",
"     <br>",
"      &bull; Patients who have received an allogeneic bone marrow transplant should not have molecular genetic testing via blood or buccal samples due to unreliable test results from contamination by donor DNA. If available, DNA should be extracted from a fibroblast culture. If the source of DNA is not possible, buccal samples can be considered, subject to the risk of donor DNA contamination.",
"      <br>",
"       &Delta; Individuals with a limited family history, such as fewer than two first- or second-degree female relatives or female relatives surviving beyond 45 years in either lineage, may have an underestimated probability of a familial mutation.",
"       <br>",
"        &loz; For the purposes of these guidelines, invasive and ductal carcinoma in situ breast cancers should be included.",
"        <br>",
"         &sect; Two breast primaries include bilateral (contralateral) disease or two or more clearly separate ipsilateral primary tumors either synchronously or asynchronously.",
"         <br>",
"          &yen; Testing for Ashkenazi Jewish founder-specific mutation(s) should be performed first. Full sequencing may be considered if ancestry also includes non-Ashkenazi Jewish relatives or other hereditary breast/ovarian cancer criteria are met. Founder mutations exist in other populations.",
"          <br>",
"           &Dagger; Testing of unaffected family members should only be considered when no affected family member is available, and then the unaffected family member with the highest probability of mutation should be tested. Significant limitations of interpreting test results should be discussed.",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     National Comprehensive Cancer Network, v1.2012 (",
"     <a href=\"file://www.nccn.org\" target=\"_blank\">",
"      www.nccn.org",
"     </a>",
"     ).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22445=[""].join("\n");
var outline_f21_58_22445=null;
var title_f21_58_22446="Clinical features of psoriatic juvenile idiopathic arthritis";
var content_f21_58_22446=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F68365&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F68365&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical features of psoriatic juvenile idiopathic arthritis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"8\" width=\"12%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Series,",
"        <br/>",
"        year",
"       </td>",
"       <td class=\"subtitle1\">",
"        Sills,",
"        <br/>",
"        1980",
"       </td>",
"       <td class=\"subtitle1\">",
"        Shore,",
"        <br/>",
"        1982",
"       </td>",
"       <td class=\"subtitle1\">",
"        Southwood,",
"        <br/>",
"        1989",
"       </td>",
"       <td class=\"subtitle1\">",
"        Truckenbrodt,",
"        <br/>",
"        1990",
"       </td>",
"       <td class=\"subtitle1\">",
"        Roberton,",
"        <br/>",
"        1996",
"       </td>",
"       <td class=\"subtitle1\">",
"        Stoll,",
"        <br/>",
"        2006",
"       </td>",
"       <td class=\"subtitle1\">",
"        Flato,",
"        <br/>",
"        2009",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Number of patients",
"        </strong>",
"       </td>",
"       <td>",
"        24",
"       </td>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        35",
"       </td>",
"       <td>",
"        48",
"       </td>",
"       <td>",
"        63",
"       </td>",
"       <td>",
"        139",
"       </td>",
"       <td>",
"        31",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Percent female",
"        </strong>",
"       </td>",
"       <td>",
"        71",
"       </td>",
"       <td>",
"        58",
"       </td>",
"       <td>",
"        69",
"       </td>",
"       <td>",
"        44",
"       </td>",
"       <td>",
"        70",
"       </td>",
"       <td>",
"        59",
"       </td>",
"       <td>",
"        77",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Arthritis appears before psoriasis",
"        </strong>",
"       </td>",
"       <td>",
"        58",
"       </td>",
"       <td>",
"        43",
"       </td>",
"       <td>",
"        48",
"       </td>",
"       <td>",
"        42",
"       </td>",
"       <td>",
"        56",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Oligoarticular onset (&lt;5 joints)",
"        </strong>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        73",
"       </td>",
"       <td>",
"        94",
"       </td>",
"       <td>",
"        85",
"       </td>",
"       <td>",
"        73",
"       </td>",
"       <td>",
"        84",
"       </td>",
"       <td>",
"        68",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Cervical spine",
"        </strong>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        32",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         TMJ",
"        </strong>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Shoulder",
"        </strong>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        9",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Elbow",
"        </strong>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        43",
"       </td>",
"       <td>",
"        20",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        33",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Wrist",
"        </strong>",
"       </td>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        62",
"       </td>",
"       <td>",
"        43",
"       </td>",
"       <td>",
"        31",
"       </td>",
"       <td>",
"        43",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        42",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        <strong>",
"         Small joints of the hand",
"        </strong>",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        88",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        60",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        31",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        62",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        61",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        MCP",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        53",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        43",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        PIP",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        40",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        51",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        DIP",
"       </td>",
"       <td class=\"sublist_other\">",
"        63",
"       </td>",
"       <td class=\"sublist_other\">",
"        42",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        27",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Sacroiliac joint",
"        </strong>",
"       </td>",
"       <td>",
"        29",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Hip",
"        </strong>",
"       </td>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        38",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        21",
"       </td>",
"       <td>",
"        32",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        23",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Knee",
"        </strong>",
"       </td>",
"       <td>",
"        67",
"       </td>",
"       <td>",
"        77",
"       </td>",
"       <td>",
"        89",
"       </td>",
"       <td>",
"        67",
"       </td>",
"       <td>",
"        84",
"       </td>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        87",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Ankle",
"        </strong>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        63",
"       </td>",
"       <td>",
"        63",
"       </td>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        51",
"       </td>",
"       <td>",
"        71",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Small joints of the foot",
"        </strong>",
"       </td>",
"       <td>",
"        67",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        46",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        56",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        42",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Any peripheral small joint",
"        </strong>",
"       </td>",
"       <td>",
"        &gt;88",
"       </td>",
"       <td>",
"        &gt;53",
"       </td>",
"       <td>",
"        69",
"       </td>",
"       <td>",
"        &gt;31",
"       </td>",
"       <td>",
"        &gt;62",
"       </td>",
"       <td>",
"        57",
"       </td>",
"       <td>",
"        65",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Dactylitis",
"        </strong>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        49",
"       </td>",
"       <td>",
"        67",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        47",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td>",
"        30",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Uveitis",
"        </strong>",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        19",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    All numbers indicate percentage of patients. Blank = not reported.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reference:",
"     <br/>",
"     <ol>",
"      <li>",
"       Stoll M, Nigrovic PA, unpublished data.",
"      </li>",
"     </ol>",
"     <br/>",
"     Data from: Nigrovic PA, Sundel RP, Petty RE. Juvenile psoriatic arthritis. In: Textbook of Pediatric Rheumatology, 6th ed, Cassidy JT, Petty RE, Laxer RM, Lindsley CB (Eds), Saunders, Philadelphia 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22446=[""].join("\n");
var outline_f21_58_22446=null;
var title_f21_58_22447="Unicornuate uter and fuse horn";
var content_f21_58_22447=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F73807&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F73807&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Unicornuate uterus with uterine horn (not containing an endometrial cavity) fused to unicornuate uterus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 358px; height: 250px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pediatric and Adolescent Gynecology, 6th ed, Emans SJ, Laufer MR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_58_22447=[""].join("\n");
var outline_f21_58_22447=null;
